Terms: = Sarcomas AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Treatment
66 results:
1. Secondary peripheral chondrosarcoma in multiple osteochondromas: a retrospective single-institution case series.
Gnoli M; Gambarotti M; Righi A; Staals EL; Evangelista A; Tremosini M; Brizola E; Mordenti M; Boarini M; Locatelli M; Pedrini E; Sangiorgi L
Orphanet J Rare Dis; 2024 Feb; 19(1):63. PubMed ID: 38351015
[TBL] [Abstract] [Full Text] [Related]
2. Engineering alginate-based injectable hydrogels combined with bioactive polymers for targeted plasma-derived oxidative stress delivery in osteosarcoma therapy.
Espona-Noguera A; Tampieri F; Canal C
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128841. PubMed ID: 38104678
[TBL] [Abstract] [Full Text] [Related]
3. High-Grade Spindle Cell Sarcoma of the Scalp With an MGA::NUTM1 Gene Fusion in a Pediatric Patient.
Arellano Zameza P; Karklins SP; Pena J; Bowers NL; Samman A; Ahn C; Sangueza OP
Am J Dermatopathol; 2024 Feb; 46(2):101-103. PubMed ID: 38055974
[TBL] [Abstract] [Full Text] [Related]
4. Biomineralized Polydopamine Nanoparticle-Based Sodium Alginate Hydrogels for Delivery of Anti-serine/Threonine Protein Kinase B-Rapidly Accelerated Fibrosarcoma siRNA for Metastatic Melanoma Therapy.
Lu J; Song J; Zhang P; Huang Y; Lu X; Dai H; Xi J
ACS Nano; 2023 Sep; 17(18):18318-18331. PubMed ID: 37690074
[TBL] [Abstract] [Full Text] [Related]
5. Atezolizumab for Advanced Alveolar Soft Part Sarcoma.
Chen AP; Sharon E; O'Sullivan-Coyne G; Moore N; Foster JC; Hu JS; Van Tine BA; Conley AP; Read WL; Riedel RF; Burgess MA; Glod J; Davis EJ; Merriam P; Naqash AR; Fino KK; Miller BL; Wilsker DF; Begum A; Ferry-Galow KV; Deshpande HA; Schwartz GK; Ladle BH; Okuno SH; Beck JC; Chen JL; Takebe N; Fogli LK; Rosenberger CL; Parchment RE; Doroshow JH
N Engl J Med; 2023 Sep; 389(10):911-921. PubMed ID: 37672694
[TBL] [Abstract] [Full Text] [Related]
6. Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
Saito A; Nishikawa T; Yoshida H; Mizoguchi C; Kitadai R; Yamamoto K; Yazaki S; Kojima Y; Ishikawa M; Kato T; Yonemori K
Gynecol Oncol; 2023 Sep; 176():115-121. PubMed ID: 37506533
[TBL] [Abstract] [Full Text] [Related]
7. Targeting the Clear Cell Sarcoma Oncogenic Driver Fusion Gene
Mae H; Outani H; Imura Y; Chijimatsu R; Inoue A; Kotani Y; Yasuda N; Nakai S; Nakai T; Takenaka S; Okada S
Cancer Res Commun; 2023 Jul; 3(7):1152-1165. PubMed ID: 37405123
[TBL] [Abstract] [Full Text] [Related]
8. Camrelizumab Plus Apatinib and Temozolomide as First-Line treatment in Patients With Advanced Acral Melanoma: The cap 03 Phase 2 Nonrandomized Clinical Trial.
Mao L; Lian B; Li C; Bai X; Zhou L; Cui C; Chi Z; Sheng X; Wang X; Tang B; Yan X; Li S; Kong Y; Dai J; Wei X; Li J; Duan R; Xu H; Wu X; Yang Y; Cheng F; Zhang C; Xia F; Pang Z; Guo J; Si L
JAMA Oncol; 2023 Aug; 9(8):1099-1107. PubMed ID: 37261804
[TBL] [Abstract] [Full Text] [Related]
9. Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood Sarcoma.
Shackleford TJ; Hariharan S; Vaseva AV; Alagoa K; Espinoza M; Bid HK; Li F; Zhong H; Phelps DA; Roberts RD; Cam H; London CA; Guttridge DC; Chen Y; Rao M; Shiio Y; Houghton PJ
Mol Cancer Ther; 2023 Apr; 22(4):539-550. PubMed ID: 36696581
[TBL] [Abstract] [Full Text] [Related]
10. Oncolytic strategy using new bifunctional HDACs/brd4 inhibitors against virus-associated lymphomas.
Chen J; Wang Z; Phuc T; Xu Z; Yang D; Chen Z; Lin Z; Kendrick S; Dai L; Li HY; Qin Z
PLoS Pathog; 2023 Jan; 19(1):e1011089. PubMed ID: 36638143
[TBL] [Abstract] [Full Text] [Related]
11. Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer.
Mateu-Sanz M; Ginebra MP; Tornín J; Canal C
Free Radic Biol Med; 2022 Aug; 189():32-41. PubMed ID: 35843475
[TBL] [Abstract] [Full Text] [Related]
12. Canady Cold Helios Plasma Reduces Soft Tissue Sarcoma Viability by Inhibiting Proliferation, Disrupting Cell Cycle, and Inducing Apoptosis: A Preliminary Report.
Ly L; Cheng X; Murthy SRK; Jones OZ; Zhuang T; Gitelis S; Blank AT; Nissan A; Adileh M; Colman M; Keidar M; Basadonna G; Canady J
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807413
[TBL] [Abstract] [Full Text] [Related]
13. Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism.
Srivastava RK; Guroji P; Jin L; Mukhtar MS; Athar M
Mol Carcinog; 2022 Aug; 61(8):737-751. PubMed ID: 35472745
[TBL] [Abstract] [Full Text] [Related]
14. Report of the First International Symposium on NUT Carcinoma.
French CA; Cheng ML; Hanna GJ; DuBois SG; Chau NG; Hann CL; Storck S; Salgia R; Trucco M; Tseng J; Stathis A; Piekarz R; Lauer UM; Massard C; Bennett K; Coker S; Tontsch-Grunt U; Sos ML; Liao S; Wu CJ; Polyak K; Piha-Paul SA; Shapiro GI
Clin Cancer Res; 2022 Jun; 28(12):2493-2505. PubMed ID: 35417004
[TBL] [Abstract] [Full Text] [Related]
15. Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma treatment.
Marchesi I; Fais M; Fiorentino FP; Bordoni V; Sanna L; Zoroddu S; Bagella L
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408939
[TBL] [Abstract] [Full Text] [Related]
16. Assembly of infectious Kaposi's sarcoma-associated herpesvirus progeny requires formation of a pORF19 pentamer.
Naniima P; Naimo E; Koch S; Curth U; Alkharsah KR; Ströh LJ; Binz A; Beneke JM; Vollmer B; Böning H; Borst EM; Desai P; Bohne J; Messerle M; Bauerfeind R; Legrand P; Sodeik B; Schulz TF; Krey T
PLoS Biol; 2021 Nov; 19(11):e3001423. PubMed ID: 34735435
[TBL] [Abstract] [Full Text] [Related]
17. Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.
Gaspar N; Venkatramani R; Hecker-Nolting S; Melcon SG; Locatelli F; Bautista F; Longhi A; Lervat C; Entz-Werle N; Casanova M; Aerts I; Strauss SJ; Thebaud E; Morland B; Nieto AC; Marec-Berard P; Gambart M; Rossig C; Okpara CE; He C; Dutta L; Campbell-Hewson Q
Lancet Oncol; 2021 Sep; 22(9):1312-1321. PubMed ID: 34416158
[TBL] [Abstract] [Full Text] [Related]
18. Radiopacity endowed magnetic nanocomposite with hyperthermia and
Sneha KR; Sreeja S; Sailaja GS
Biomed Mater; 2021 May; 16(4):. PubMed ID: 34061045
[TBL] [Abstract] [Full Text] [Related]
19. Vimentin-positive and Alpha-fetoprotein-elevated Nuclear Protein of the Testis Midline Carcinoma: A Case Report and Review of the Literature.
Murano C; Suzuki S; Nakamura S; Takeda H; Fukui T; Yoshioka T
Intern Med; 2021 Nov; 60(22):3645-3649. PubMed ID: 34053984
[TBL] [Abstract] [Full Text] [Related]
20. Augmented Antitumor Activity for Novel Dual PI3K/BDR4 Inhibitors, SF2523 and SF1126 in Ewing Sarcoma.
Goldin AN; Singh A; Joshi S; Jamieson C; Durden DL
J Pediatr Hematol Oncol; 2021 Apr; 43(3):e304-e311. PubMed ID: 33480647
[TBL] [Abstract] [Full Text] [Related]
[Next]
